UPI - Friday, February 11, 2005 
  
Date: Friday, February 11, 2005 4:04:53 PM EST

BOSTON, Feb. 11 (UPI) -- U.S. and Swiss researchers have designed a 
new drug to treat chronic myelogenous leukemia that ultimately could 
be more effective than the current treatment.

Researchers from the Dana-Farber Cancer Institute in Boston and 
Novartis Pharmaceuticals in Basel, Switzerland, created a drug based 
on Gleevec, the current treatment, that causes longer remissions. 
Approximately 95 percent of CML patients treated with Gleevec 
currently achieve remission.

Gleevec blocks the growth of an abnormal protein present in leukemia 
cells, but it only blocks growth briefly, because it does not bond 
strongly to the protein and patients eventually develop a resistance.

The researchers determined the crystal structure of the abnormal 
protein and constructed a compound that would lock onto the receptor 
more securely than Gleevec.

In experiments with laboratory samples of leukemia cells, the new 
drug killed the cells more effectively than Gleevec, and in follow-
up studies with mice it produced lengthier remissions.

Researchers are testing new drug at the M.D. Anderson Cancer Center 
and if proven safe, it will be tested on CML patients at Dana-Farber 
and other sites, they said.


--
Copyright 2005 by United Press International.
All rights reserved.

 






------------------------ Yahoo! Groups Sponsor --------------------~--> 
Help save the life of a child.  Support St. Jude Children's Research Hospital's
'Thanks & Giving.'
http://us.click.yahoo.com/0iazvD/5WnJAA/xGEGAA/8zSolB/TM
--------------------------------------------------------------------~-> 

New! Sign up for local CML support group meetings in your local community at 
http://cml.meetup.com

Apply for Commercial Real Estate loans online and submit your deal to dozens of 
hungry lenders in just minutes. Loan programs for all types of business and 
commercial real estate. Apply anytime at http://realestatezoo.com 

CML (Chronic Myelogenous Leukemia Support List) 
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com 

Post Message: [email protected] 
Subscribe:  [EMAIL PROTECTED] 
Unsubscribe:  [EMAIL PROTECTED] 
Change To No Mail/Web: [EMAIL PROTECTED] 
Change To Digest: [EMAIL PROTECTED] 
Change To Email: [EMAIL PROTECTED] 
List Help: [EMAIL PROTECTED]  
CML Group Web Site http://groups.yahoo.com/group/CML 
 
Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/CML/

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 


Reply via email to